Quantication and 24-hour monitoring of mycophenolic acid by high-performance liquid chromatography in Japanese renal transplant recipients

Yakugaku Zasshi

Volumn 126, Issue 12, 2006, Pages 1357-1362

  Kagaya, Hideaki ^a   Inoue, Kazuyuki ^a   Miura, Masatomo ^a   Satoh, Shigeru ^b   Saito, Mitsuru ^b   Tada, Hitoshi ^a   Habuchi, Tomonori ^b   Suzuki, Toshio ^a  

^a AKITA UNIVERSITY HOSPITAL   (Japan)

^b AKITA UNIVERSITY   (Japan)

Author keywords

24h monitoring; High performance liquid chromatography; Mycophenolic acid

Indexed keywords

ACETONITRILE; METHANOL; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NAPROXEN; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; TACROLIMUS;

AREA UNDER THE CURVE; ARTICLE; DRUG BLOOD LEVEL; GRAFT RECIPIENT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; JAPANESE; KIDNEY GRAFT; LIQUID LIQUID EXTRACTION; MULTIPLE CYCLE TREATMENT; ASIAN; BLOOD; DRUG ADMINISTRATION; DRUG COMBINATION; KIDNEY TRANSPLANTATION; METHODOLOGY; MONITORING; SENSITIVITY AND SPECIFICITY; TIME;

ASIAN CONTINENTAL ANCESTRY GROUP; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MONITORING, PHYSIOLOGIC; MYCOPHENOLIC ACID; PREDNISOLONE; SENSITIVITY AND SPECIFICITY; TACROLIMUS; TIME FACTORS;

EID: 33846177887     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.126.1357     Document Type: Article

References (29)

1. Roth D., Colona J., Burke G. W., Ciancio G., Esquenazi V., Miller J., Transplantation, 27, 248-252 (1998).
2. Squifflet J. P., Backman L., Claesson K., Dietl K. H., Ekberg H., Forsythe J. L., Kunzendorf U., Heemann U., Land W., Morales J. M., Muhlbacher F., Talbot D., Taube D., Tyden G., Hooff J., Schleibner S., Vanrenterghem Y., Transplantation, 15, 63-69 (2001).
3. Bullingham R. E., Nicholls A. J., Kamm B. R., Clin. Pharmacokinet., 34, 429-455 (1998).
4. Shaw L. M., Holt D. W., Oellerich M., Meiser B., Van Gelder T., Ther. Drug Monit., 23, 305-315 (2001).
5. Basu N. K., Kole L., Kubota S., Owens I. S., Drug Metab. Dispos., 32, 768-773 (2004).
6. Picard N., Ratanasavanh D., Premaud A., Le Meur Y., Marquet P., Drug Metab. Dispos., 33, 139-146 (2005).
7. Bernard O., Guillemette C., Drug Metab. Dispos., 32, 775-778 (2004).
8. Holt D. W., Ann. Clin. Biochem., 39, 173-183 (2002).
9. Mourad M., Wallemacq P., Konig J., de Frahan E. H., Eddour D. C., De Meyer M., Malaise J., Squifflet J. P., Clin. Pharmacokinet., 41, 319-327 (2002).
10. Hale M. D., Nicholls A. J., Bullingham R. E., Hene R., Hoitsma A., Squifflet J. P., Weimar W., Vanrenterghem Y., Van de Woude F. J., Verpooten G. A., Clin. Pharmacol. Ther., 64, 672-683 (1998).
11. Pillans P. I., Rigby R. J., Kubler P., Willis C., Salm P., Tett S. E., Taylor P. J., Clin. Biochem., 34, 77-81 (2001).
12. Takahashi K., Ochiai T., Uchida K., Yasumura T., Ishibashi M., Suzuki S., Otsubo O., Isono K., Takagi H., Oka T., Transplant. Proc., 27, 1421-1424 (1995).
13. Kuypers D. R., Naesens M., Vermeire S., Vanrenterghem Y., Clin. Pharmacol. Ther., 78, 351-361 (2005).
14. Cox V. C., Ensom M. H., Ther. Drug Monit., 25, 137-157 (2003).
15. Hosotsubo H., Takahara S., Imamura R., Kyakuno M., Tanaka T., Yazawa K., Hanafusa T., Matsumiya K., Nonomura N., Okuyama A., Sugimoto H., Ther. Drug Monit., 23, 669-674 (2001).
16. Pastore A., Lo Russo A., Piemonte F., Mannucci L., Federici G., J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 776, 251-254 (2002).
17. Teshima D., Kitagawa N., Otsubo K., Makino K., Itoh Y., Oishi R., J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 780, 21-26 (2002).
18. Zambonin C. G., Aresta A., Palmisano F., J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 806, 89-93 (2004).
19. Bolon M., Jeanpierre L., El Barkil M., Chelbi K., Sauviat M., Boulieu R., J. Pharm. Biomed. Anal., 36, 649-651 (2004).
20. Jones C. E., Taylor P. J., Johnson A. G., J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 708, 229-234 (1998).
21. Patel C. G., Mendonza A. E., Akhlaghi F., Majid O., Trull A. K., Lee T., Holt D. W., J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 813, 287-294 (2004).
22. Shipkova M., Niedmann P. D., Amstrong V. W., Schutz E., Wieland E., Shaw L. M., Oellerich M., Clin. Chem., 44, 1481-1488 (1998).
23. Shipkova M., Schütz E., Armstrong V. W., Niedmann P. D., Oellerich M., Wieland E., Clin. Chem., 46, 365-372 (2000).
24. Tsina I., Chu F., Hama K., Kaloostian M., Tam Y. L., Tarnowski T., Wong B., J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 675, 119-129 (1996).
25. Westley I. S., Sallustio B. C., Morris R. G., Clin. Biochem., 38, 824-829 (2005).
26. Indjova D., Kassabova L., Svinarov D., J. Chromatogr. BAnalyt. Technol. Biomed. Life Sci., 817, 327-330 (2005).
27. US Department of Health and Human Services, Food and Drug Administration, Guidance for Industry Bioanalytical Method Validation. 〈http://www.fda. gov/cder/guidance/4252fnl.pdf 2001〉.
28. Shah V. P., Midha K. K., Dighe S. V., Pharm. Res., 9, 588-592 (1992).
29. Shaw L. M., Mick R., Nowak I., Korecka M., Brayman K. L., J. Clin. Pharmacol., 38, 268-275 (1998).